Sign up to save your podcasts
Or
Share Persistent low level HIV viremia - Trip Gulick, MD/ Michael Saag, MD
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Persistent low level HIV viremia - Trip Gulick, MD/ Michael Saag, MD
A 42-year-old woman newly diagnosed with HIV (CD4 425, HIV RNA 73,000, genotype with wild-type virus) starts tenofovir alafenamide/emtricitabine/bictegravir and has the following virologic response:
Weeks of Therapy HIV Viral Load
4 weeks HIV RNA 9,400
8 weeks HIV RNA 1,050
16 weeks HIV RNA 105
24 weeks HIV RNA 90
36 weeks HIV RNA 67
48 weeks HIV RNA 82
In addition to reinforcing adherence, what would you recommend?
A. Add darunavir/ritonavir
B. Add etravirine
C. Add darunavir/ritonavir and etravirine
D. Switch bictegravir to darunavir/ritonavir
E. Continue current regimen
www.idbrcourse.org/ © 2024 IDBR LLC | All Rights Reserved
View all episodes
By John Bennett, MD / Henry Masur, MD
5
22 ratings
A 42-year-old woman newly diagnosed with HIV (CD4 425, HIV RNA 73,000, genotype with wild-type virus) starts tenofovir alafenamide/emtricitabine/bictegravir and has the following virologic response:
Weeks of Therapy HIV Viral Load
4 weeks HIV RNA 9,400
8 weeks HIV RNA 1,050
16 weeks HIV RNA 105
24 weeks HIV RNA 90
36 weeks HIV RNA 67
48 weeks HIV RNA 82
In addition to reinforcing adherence, what would you recommend?
A. Add darunavir/ritonavir
B. Add etravirine
C. Add darunavir/ritonavir and etravirine
D. Switch bictegravir to darunavir/ritonavir
E. Continue current regimen
www.idbrcourse.org/ © 2024 IDBR LLC | All Rights Reserved